KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Moderna (MRNA) Receivables - Net (2017 - 2026)

Moderna (MRNA) has disclosed Receivables - Net for 10 consecutive years, with $203.0 million as the latest value for Q1 2026.

  • For Q1 2026, Receivables - Net fell 18.47% year-over-year to $203.0 million; the TTM value through Mar 2026 reached $203.0 million, down 18.47%, while the annual FY2025 figure was $184.0 million, 48.6% down from the prior year.
  • Receivables - Net hit $203.0 million in Q1 2026 for Moderna, up from $184.0 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $3.2 billion in Q1 2022 and bottomed at $36.0 million in Q2 2025.
  • Average Receivables - Net over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2023.
  • Year-over-year, Receivables - Net skyrocketed 112.07% in 2024 and then tumbled 92.68% in 2025.
  • Moderna's Receivables - Net stood at $1.4 billion in 2022, then rose by 14.37% to $1.6 billion in 2023, then crashed by 77.4% to $358.0 million in 2024, then plummeted by 48.6% to $184.0 million in 2025, then rose by 10.33% to $203.0 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $203.0 million, $184.0 million, and $2.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.